Current Opinion in Organ Transplantation was launched in 1996. It is part of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The field of organ transplantation is divided into 18 sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Section Editors for this issue. SECTION EDITORS Philip J. O’ConnellPhilip J. O’ConnellAfter completing his clinical training in Nephrology in Sydney, Philip J. O’Connell undertook a PhD in endothelial cell adhesion molecules with Professor Tony d’Apice at the Royal Melbourne Hospital. He then had further training in transplant immunology as a post-doctoral research fellow with Professor Terry Strom, Harvard Medical School. It was here that he developed an interest in islet transplantation and following two and a half years in Boston he took up a position as a transplant nephrologist at the National Pancreas Transplant Unit, Westmead Hospital. It was here that he set up a research group investigating the mechanisms of islet xenograft rejection and developed the laboratory skills necessary of clinical grade islet isolation. In 2003 he initiated the first successful clinical trial of clinical islet transplantation in Australia. He is Director of the Australian Clinical Islet Transplant Consortium, which undertook Australia's first multicentre clinical trial of islet transplantation and now provides a national clinical service for patients with unstable type 1 diabetes. He maintains a strong research interest in the use of genomics as a marker of renal allograft dysfunction. Currently he is a clinical professor in Medicine at the University of Sydney and Director of Transplantation at Westmead Hospital. He is also Director of the Centre for Transplant and Renal Research, The Westmead Institute of Medical Reseach where his major research focus has been the development of pancreatic islet transplantation as a main stream treatment for type 1 diabetes. His research group still has a strong research program in islet xenotransplantation. He is immediate Past-President of The Transplantation Society and Past-President of the Transplantation Society of Australia and New Zealand. Stefan SchneebergerStefan SchneebergerCurrently, I am serving as the Vice Chair and Head of Transplant and Hepatobiliary Surgery and Associate Professor of Surgery at the Department of Visceral, Transplant and Thoracic Surgery at the Innsbruck Medical University in Austria. I received my medical degree at the Leopold Franzens University in Innsbruck/Austria in 1999, and completed residency in general surgery at the Innsbruck Medical University. I was then appointed a faculty position at the Innsbruck Medical University/Department of Visceral, Transplant and Thoracic Surgery. The emphasis of my clinical work is solid organ transplantation and hepatobiliary surgery while the particular focus of my basic science as well as translational research efforts are vascularized composite allotransplantation, rejection and ischemia/reperfusion injury. In 2006, I was appointed Research Assistant Professor of Surgery at the Division of Plastic Surgery at the University of Pittsburgh Medical Center, USA and later served as the Director of the Composite Tissue Allotransplantation Program in Pittsburgh until 2010. Commuting between Baltimore and Innsbruck, I served as Associate Professor of Surgery at the Innsbruck Medical University and Visiting (later Adjunct) Associate Professor part-time at the Johns Hopkins Medical University in Baltimore, USA until end of 2013. In 2014, I completed an Executive MBA Program in General Management at the University of St. Gallen in Switzerland. Currently, I am at Innsbruck full time. Awards received include the Roche Austrotransplant Award in 2004, the Young Investigator Award from the American Society for Transplantation in 2005, the Austrotransplant Award in 2008, the American Society for Reconstructive Transplantation Achievement Award in 2010 and the Pichlmayr Preis in 2013. I was the Founder and first President of the American Society for Reconstructive Transplantation as well as the ESOT Composite Tissue Allotransplantation Committee. I am President Elect of the European Society for Organ Transplantation (ESOT) and Co-Chair the Scientific Program Committee for the upcoming ESOT conference in Barcelona in 2017 together with Josep Grinyo. The list of publications I have worked on includes over 110 original articles, 14 review articles, 24 book chapters and over 350 published abstracts. I have presented 97 invited lectures and served as chair or key member of the organizing committee of several international conferences.